US2956062A
(en)
|
1959-02-26 |
1960-10-11 |
Robins Co Inc A H |
Esters of amino alcohols
|
US3175299A
(en)
*
|
1961-08-02 |
1965-03-30 |
American Sugar |
Method of drying sugar crystals with acoustic energy and a gas
|
US3994974A
(en)
|
1972-02-05 |
1976-11-30 |
Yamanouchi Pharmaceutical Co., Ltd. |
α-Aminomethylbenzyl alcohol derivatives
|
SE378109B
(tr)
|
1972-05-19 |
1975-08-18 |
Bofors Ab |
|
US4187301A
(en)
|
1978-04-05 |
1980-02-05 |
Syntex (U.S.A.) Inc. |
17 Beta-thiocarboxylic acid esters of 6 alpha, 6 beta-difluoro-3-oxoandrost-4-enes
|
JPS56138200A
(en)
|
1980-02-15 |
1981-10-28 |
Glaxo Group Ltd |
Androstane carbothioate compound
|
DE3260474D1
(en)
|
1981-02-02 |
1984-09-06 |
Schering Corp |
Aromatic heterocyclic esters of steroids, their preparation and pharmaceutical compositions containing them
|
DE3268533D1
(en)
*
|
1981-07-24 |
1986-02-27 |
Fisons Plc |
Inhalation drugs, methods for their production and pharmaceutical formulations containing them
|
ZW6584A1
(en)
|
1983-04-18 |
1985-04-17 |
Glaxo Group Ltd |
Phenethanolamine derivatives
|
GB8432063D0
(en)
|
1984-12-19 |
1985-01-30 |
Riker Laboratories Inc |
Physically modified steroids
|
US5707634A
(en)
|
1988-10-05 |
1998-01-13 |
Pharmacia & Upjohn Company |
Finely divided solid crystalline powders via precipitation into an anti-solvent
|
GB8903593D0
(en)
|
1989-02-16 |
1989-04-05 |
Pafra Ltd |
Storage of materials
|
ATE92762T1
(de)
|
1989-09-08 |
1993-08-15 |
Glaxo Group Ltd |
Medikamente.
|
IL95590A
(en)
|
1989-09-08 |
1996-06-18 |
Glaxo Group Ltd |
Medicinal preparations containing Salmetrol and Pluticasone Propionate
|
DE3931041C2
(de)
|
1989-09-16 |
2000-04-06 |
Boehringer Ingelheim Kg |
Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
|
US5610163A
(en)
|
1989-09-16 |
1997-03-11 |
Boehringer Ingelheim Gmbh |
Esters of thienyl carboxylic acids and amino alcohols and their quaternization products
|
SG45171A1
(en)
|
1990-03-21 |
1998-01-16 |
Boehringer Ingelheim Int |
Atomising devices and methods
|
DK0548114T5
(da)
|
1990-09-10 |
1995-01-30 |
Schering Corp |
Mometason-furoat-monohydrat, fremgangsmåde til fremtilling deraf og farmaceutiske præparater indeholdende dette
|
DE4108393A1
(de)
|
1991-03-15 |
1992-09-17 |
Boehringer Ingelheim Kg |
Neue ester bi- und tricyclischer aminoalkohole, ihre herstellung und ihre verwendung in arzneimitteln
|
SE9101090D0
(sv)
*
|
1991-04-11 |
1991-04-11 |
Astra Ab |
Process for conditioning of water-soluble substances
|
SE9302777D0
(sv)
*
|
1993-08-27 |
1993-08-27 |
Astra Ab |
Process for conditioning substances
|
US5874063A
(en)
|
1991-04-11 |
1999-02-23 |
Astra Aktiebolag |
Pharmaceutical formulation
|
AU659645B2
(en)
|
1991-06-26 |
1995-05-25 |
Inhale Therapeutic Systems |
Storage of materials
|
DE69232462T2
(de)
|
1991-12-18 |
2002-10-10 |
Astrazeneca Ab |
Formoterol und budesonide enthaltende zusammensetzung
|
US6582728B1
(en)
|
1992-07-08 |
2003-06-24 |
Inhale Therapeutic Systems, Inc. |
Spray drying of macromolecules to produce inhaleable dry powders
|
US5849263A
(en)
|
1993-03-30 |
1998-12-15 |
Charlotte-Mecklenburg Hospital Authority |
Pharmaceutical compositions containing alkylaryl polyether alcohol polymer
|
GB9313642D0
(en)
|
1993-07-01 |
1993-08-18 |
Glaxo Group Ltd |
Method and apparatus for the formation of particles
|
EP0731688B1
(en)
|
1993-12-02 |
2003-03-05 |
Abbott Laboratories |
Aerosol drug formulations for use with non-cfc propellants
|
SE9404080L
(sv)
|
1993-12-28 |
1995-06-29 |
Ciba Geigy Ag |
Förfarande för framställning av en optiskt ren enantiomer av formoterol
|
US5837699A
(en)
|
1994-01-27 |
1998-11-17 |
Schering Corporation |
Use of mometasone furoate for treating upper airway passage diseases
|
AU680727B2
(en)
|
1994-02-09 |
1997-08-07 |
Kinerton Limited |
Process for drying a material from solution
|
GB9413202D0
(en)
|
1994-06-30 |
1994-08-24 |
Univ Bradford |
Method and apparatus for the formation of particles
|
DE4440337A1
(de)
|
1994-11-11 |
1996-05-15 |
Dds Drug Delivery Services Ges |
Pharmazeutische Nanosuspensionen zur Arzneistoffapplikation als Systeme mit erhöhter Sättigungslöslichkeit und Lösungsgeschwindigkeit
|
WO1996019198A1
(en)
|
1994-12-22 |
1996-06-27 |
Astra Aktiebolag |
Aerosol drug formulations
|
US5612053A
(en)
|
1995-04-07 |
1997-03-18 |
Edward Mendell Co., Inc. |
Controlled release insufflation carrier for medicaments
|
GB9507768D0
(en)
|
1995-04-13 |
1995-05-31 |
Glaxo Group Ltd |
Method of apparatus
|
US6258341B1
(en)
|
1995-04-14 |
2001-07-10 |
Inhale Therapeutic Systems, Inc. |
Stable glassy state powder formulations
|
US6309671B1
(en)
|
1995-04-14 |
2001-10-30 |
Inhale Therapeutic Systems |
Stable glassy state powder formulations
|
JP3708553B2
(ja)
|
1995-04-14 |
2005-10-19 |
ネクター セラピューティクス |
向上した分散性を有する粉末型薬理組成物
|
US5833891A
(en)
|
1996-10-09 |
1998-11-10 |
The University Of Kansas |
Methods for a particle precipitation and coating using near-critical and supercritical antisolvents
|
DE19614421C2
(de)
|
1996-04-12 |
1999-12-16 |
Biovision Gmbh |
Verfahren zur Herstellung eines biodegradierbaren Knochenersatz- und Implantatwerkstoffes und biodegradierbarer Knochenersatz- und Implantatwerkstoff
|
GB9610821D0
(en)
|
1996-05-23 |
1996-07-31 |
Glaxo Wellcome Inc |
Metering apparatus
|
US6054488A
(en)
|
1996-06-11 |
2000-04-25 |
3M Innovative Properties Company |
Medicinal aerosol formulations of formoterol
|
GB9612297D0
(en)
|
1996-06-11 |
1996-08-14 |
Minnesota Mining & Mfg |
Medicinal aerosol formulations
|
US5886200A
(en)
|
1996-07-01 |
1999-03-23 |
Schering Corporation |
Process for the preparation of 17-esters of 9 α, 21-dihalo-pregnane-11 β, 17 α-diol-20-ones
|
US6068832A
(en)
|
1996-08-29 |
2000-05-30 |
Schering Corporation |
Chlorofluorocarbon-free mometasone furoate aerosol formulations
|
US6040344A
(en)
|
1996-11-11 |
2000-03-21 |
Sepracor Inc. |
Formoterol process
|
SE9700135D0
(sv)
|
1997-01-20 |
1997-01-20 |
Astra Ab |
New formulation
|
CZ295460B6
(cs)
|
1997-03-20 |
2005-08-17 |
Schering Corporation |
Způsob výroby aglomerátů a jednotková dávka farmakologicky aktivní látky je obsahující
|
US6129905A
(en)
|
1997-04-21 |
2000-10-10 |
Aeropharm Technology, Inc. |
Aerosol formulations containing a sugar as a dispersant
|
US6010935A
(en)
|
1997-08-21 |
2000-01-04 |
Micron Technology, Inc. |
Self aligned contacts
|
SE9703407D0
(sv)
|
1997-09-19 |
1997-09-19 |
Astra Ab |
New use
|
US6565885B1
(en)
|
1997-09-29 |
2003-05-20 |
Inhale Therapeutic Systems, Inc. |
Methods of spray drying pharmaceutical compositions
|
US6309623B1
(en)
|
1997-09-29 |
2001-10-30 |
Inhale Therapeutic Systems, Inc. |
Stabilized preparations for use in metered dose inhalers
|
SK285068B6
(sk)
|
1997-09-29 |
2006-05-04 |
Nektar Therapeutics |
Práškový prostriedok, mikrosféry, spôsob tvorby časticového prostriedku obsahujúceho perforované mikroštruktúry prostredníctvom sušenia striekaním a spôsob tvorby prášku obsahujúceho perforované mikroštruktúry prostredníctvom sušenia striekaním
|
US6946117B1
(en)
|
1997-09-29 |
2005-09-20 |
Nektar Therapeutics |
Stabilized preparations for use in nebulizers
|
US6433040B1
(en)
|
1997-09-29 |
2002-08-13 |
Inhale Therapeutic Systems, Inc. |
Stabilized bioactive preparations and methods of use
|
US20060165606A1
(en)
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
GB9808470D0
(en)
†
|
1998-04-22 |
1998-06-17 |
Smithkline Beecham Plc |
Novel process and apparatus
|
US6260549B1
(en)
|
1998-06-18 |
2001-07-17 |
Clavius Devices, Inc. |
Breath-activated metered-dose inhaler
|
US6451285B2
(en)
|
1998-06-19 |
2002-09-17 |
Baker Norton Pharmaceuticals, Inc. |
Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
|
ATE234604T1
(de)
|
1998-08-04 |
2003-04-15 |
Jago Res Ag |
Medizinische aerosolformulierungen
|
ES2192866T3
(es)
|
1998-11-13 |
2003-10-16 |
Jago Res Ag |
Polvo seco para inhalacion.
|
GB9912639D0
(en)
|
1999-05-28 |
1999-07-28 |
Britannia Pharmaceuticals Ltd |
Improvements in and relating to treatment of respiratory conditions
|
GB9826284D0
(en)
*
|
1998-12-01 |
1999-01-20 |
Rhone Poulence Rorer Limited |
Process
|
CA2356637C
(en)
|
1998-12-22 |
2011-09-13 |
The University Of North Carolina At Chapel Hill |
Compounds and methods for the treatment of airway diseases and for the delivery of airway drugs
|
GB9902689D0
(en)
|
1999-02-08 |
1999-03-31 |
Novartis Ag |
Organic compounds
|
GB9903759D0
(en)
|
1999-02-18 |
1999-04-14 |
Novartis Ag |
Organic compounds
|
GB9904919D0
(en)
|
1999-03-03 |
1999-04-28 |
Novartis Ag |
Organic compounds
|
DE69936268T2
(de)
|
1999-03-05 |
2008-02-14 |
Chiesi Farmaceutici S.P.A. |
Verbesserte pulverförmige pharmazeutische Zusammensetzungen zur Verwendung in Trockenpulverinhalatoren
|
SE9900833D0
(sv)
|
1999-03-09 |
1999-03-09 |
Astra Ab |
Novel combination
|
DE19921693A1
(de)
|
1999-05-12 |
2000-11-16 |
Boehringer Ingelheim Pharma |
Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
|
US7090831B1
(en)
|
1999-04-14 |
2006-08-15 |
Smithkline Beecham Corporation |
Pharmaceutical aerosol formulation
|
US20100197719A1
(en)
|
1999-05-12 |
2010-08-05 |
Boehringer Ingelheim Pharma Kg |
Medicament compositions containing anticholinergically-effective compounds and betamimetics
|
US6255320B1
(en)
*
|
1999-06-01 |
2001-07-03 |
Pfizer Inc. |
Polymorphs of a crystalline azo-bicyclo (2,2,2) octan-3-amine citrate and their pharmaceutical compositions
|
AU5105100A
(en)
*
|
1999-06-03 |
2000-12-28 |
Eisai Co. Ltd. |
Crystals of carbapenem derivatives and pharmaceutical preparations for injection
|
DE60036214T2
(de)
*
|
1999-06-30 |
2008-05-21 |
Nektar Therapeutics, San Carlos |
Verfahren und system zur herstellung von trockenem pulver mittels sprühtrocknung
|
ES2165768B1
(es)
|
1999-07-14 |
2003-04-01 |
Almirall Prodesfarma Sa |
Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
|
PT102343B
(pt)
|
1999-08-02 |
2003-11-28 |
Hovione Farmaciencia Sa |
Processo para a preparacao de furoato mometasona
|
US6586008B1
(en)
|
1999-08-25 |
2003-07-01 |
Advanced Inhalation Research, Inc. |
Use of simple amino acids to form porous particles during spray drying
|
EP1666028B1
(en)
|
1999-10-29 |
2010-03-24 |
Novartis AG |
Dry powder compositions having improved dispersivity
|
US6596261B1
(en)
|
2000-01-25 |
2003-07-22 |
Aeropharm Technology Incorporated |
Method of administering a medicinal aerosol formulation
|
IT1317846B1
(it)
|
2000-02-22 |
2003-07-15 |
Chiesi Farma Spa |
Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
|
GB0008660D0
(en)
|
2000-04-07 |
2000-05-31 |
Arakis Ltd |
The treatment of respiratory diseases
|
US7442388B2
(en)
|
2000-05-10 |
2008-10-28 |
Weers Jeffry G |
Phospholipid-based powders for drug delivery
|
US20060257324A1
(en)
|
2000-05-22 |
2006-11-16 |
Chiesi Farmaceutici S.P.A. |
Pharmaceutical solution formulations for pressurised metered dose inhalers
|
US20040081627A1
(en)
|
2000-10-09 |
2004-04-29 |
Jinks Phillip A |
Medicinal aerosol formulations
|
US6908928B2
(en)
|
2000-10-12 |
2005-06-21 |
Bi Pharma Kg. |
Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions
|
ES2708961T3
(es)
|
2000-11-30 |
2019-04-12 |
Vectura Ltd |
Composiciones farmacéuticas para inhalación
|
GB0030074D0
(en)
*
|
2000-12-08 |
2001-01-24 |
Univ London Pharmacy |
Particulate inhalation carrier
|
US20020141946A1
(en)
|
2000-12-29 |
2002-10-03 |
Advanced Inhalation Research, Inc. |
Particles for inhalation having rapid release properties
|
ITMI20010428A1
(it)
|
2001-03-02 |
2002-09-02 |
Chemo Breath S A |
Composizioni ad uso inalatorio a base di formoterolo
|
BR0208012A
(pt)
|
2001-03-20 |
2004-03-02 |
Glaxo Group Ltd |
Usos de pelo menos duas drogas e um propelente hfa e de pelo menos uma composição farmaceêutica, e, inalador acondicionado para tratar asma
|
AU2002234476B2
(en)
|
2001-03-30 |
2006-04-27 |
Jagotec Ag |
Medical aerosol formulations
|
US6667344B2
(en)
|
2001-04-17 |
2003-12-23 |
Dey, L.P. |
Bronchodilating compositions and methods
|
US6848197B2
(en)
|
2001-04-18 |
2005-02-01 |
Advanced Inhalation Research, Inc. |
Control of process humidity to produce large, porous particles
|
DE10120484A1
(de)
*
|
2001-04-25 |
2002-10-31 |
Degussa |
Verfahren und Vorrichtung zur thermischen Behandlung von pulverförmigen Stoffen
|
DE10130371A1
(de)
|
2001-06-23 |
2003-01-02 |
Boehringer Ingelheim Pharma |
Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika
|
US20030018019A1
(en)
|
2001-06-23 |
2003-01-23 |
Boehringer Ingelheim Pharma Kg |
Pharmaceutical compositions based on anticholinergics, corticosteroids and betamimetics
|
TWI324934B
(en)
|
2001-08-28 |
2010-05-21 |
Schering Corp |
Pharmaceutical compositions for the treatment of asthma
|
DE10202940A1
(de)
|
2002-01-24 |
2003-07-31 |
Sofotec Gmbh & Co Kg |
Patrone für einen Pulverinhalator
|
CA2478607A1
(en)
|
2002-03-07 |
2003-09-18 |
Avalon Pharmaceuticals |
Cancer-linked gene as target for chemotherapy
|
DE10214264A1
(de)
|
2002-03-28 |
2003-10-16 |
Boehringer Ingelheim Pharma |
HFA-Suspensionsformulierungen eines Anhydrats
|
GB0207906D0
(en)
|
2002-04-05 |
2002-05-15 |
3M Innovative Properties Co |
Formoterol and mometasone aerosol formulations
|
DE10216429A1
(de)
|
2002-04-12 |
2003-10-23 |
Boehringer Ingelheim Pharma |
Arzneimittel enthaltend Steroide und ein neues Anticholinergikum
|
EP1511500A4
(en)
|
2002-06-12 |
2009-04-29 |
Epigenesis Pharmaceuticals Llc |
COMBINATION OF ANTI-MUSCARINIC AGENTS AND NONGLUCOCORTICOID STEROIDS
|
DE10237739A1
(de)
|
2002-08-17 |
2004-02-26 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Inhalative Arzneimittel enthaltend ein neues Anticholinergikum in Kombination mit Corticosteroiden und Betamimetika
|
US7244742B2
(en)
|
2002-08-17 |
2007-07-17 |
Boehringer Ingelheim Pharma Gmbh & Co Kg |
Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic
|
ATE443005T1
(de)
|
2002-10-15 |
2009-10-15 |
Cryovac Inc |
Verfahren zum auslösen, lagern und abgeben eines sauerstoffaufnehmers sowie gelagerter sauerstoffaufnehmer
|
US20040121003A1
(en)
|
2002-12-19 |
2004-06-24 |
Acusphere, Inc. |
Methods for making pharmaceutical formulations comprising deagglomerated microparticles
|
DE10323966A1
(de)
|
2003-05-27 |
2004-12-16 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue langwirksame Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen
|
EP1635786A2
(en)
|
2003-05-28 |
2006-03-22 |
Nektar Therapeutics |
Spray drying of an alcoholic aqueous solution for the manufacture of a water-insoluble active agent microparticle with a partial or complete amino acid and/or phospholipid coat
|
CA2529007C
(en)
|
2003-06-16 |
2012-03-27 |
Altana Pharma Ag |
Composition comprising a pulmonary surfactant and a pde5 inhibitor for the treatment of lung diseases
|
SE527190C2
(sv)
|
2003-06-19 |
2006-01-17 |
Microdrug Ag |
Inhalatoranordning samt kombinerade doser av en beta2-agonist, ett antikolinergiskt medel och ett antiinflammatorisk steroid
|
DE602004019096D1
(de)
|
2003-07-28 |
2009-03-05 |
Boehringer Ingelheim Pharma |
Medikamente zur inhalation mit betamimetika und einem anticholinergikum
|
ATE357258T1
(de)
|
2003-07-29 |
2007-04-15 |
Boehringer Ingelheim Int |
Medikamente zur inhalation mit betamimetika und einem anticholinergikum
|
EP1651236A1
(en)
|
2003-07-29 |
2006-05-03 |
Boehringer Ingelheim International GmbH |
Combination of an anticholinergic and a steroid and its use to treat respiratory disorders by inhalation
|
ATE526967T1
(de)
|
2003-07-31 |
2011-10-15 |
Boehringer Ingelheim Int |
Medikamente für inhalationen enthaltend ein anticholinergikum und ein betamimetikum
|
US9308199B2
(en)
|
2004-04-29 |
2016-04-12 |
Honeywell International Inc. |
Medicament formulations
|
SE0303270L
(sv)
|
2003-12-03 |
2005-06-04 |
Microdrug Ag |
Metod för administration av tiotropium
|
AU2005210083B2
(en)
|
2004-02-06 |
2010-03-11 |
Meda Pharma Gmbh & Co. Kg |
Novel combination of anticholinergic and beta mimetics for the treatment of respiratory diseases
|
JP4819699B2
(ja)
|
2004-02-06 |
2011-11-24 |
メダ ファーマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディト ゲゼルシャフト |
喘息及びcopdの長期間の治療のための抗コリン作用薬及びグルココルチコイドの組合せ剤
|
US20050287077A1
(en)
|
2004-02-10 |
2005-12-29 |
James E. Shipley |
Process for preparing stable SOL of pharmaceutical ingredients and hydrofluorocarbon
|
GB0409703D0
(en)
†
|
2004-04-30 |
2004-06-02 |
Vectura Ltd |
Pharmaceutical compositions
|
GB0411056D0
(en)
|
2004-05-18 |
2004-06-23 |
Novartis Ag |
Organic compounds
|
EP1755720A1
(en)
*
|
2004-05-20 |
2007-02-28 |
Discovery Laboratories, Inc. |
Methods , systems and devices for noninvasive pulmonary delivery
|
WO2006002178A1
(en)
|
2004-06-18 |
2006-01-05 |
Novartis Vaccines And Diagnostics Inc. |
Methods of treatment of endobronchial infections
|
GB0426301D0
(en)
|
2004-11-30 |
2004-12-29 |
Vectura Ltd |
Pharmaceutical formulations
|
JP2008534480A
(ja)
|
2005-03-24 |
2008-08-28 |
ソーセイ アールアンドディ リミテッド |
グリコピロニウム塩およびそれらの治療的使用
|
MX2007012084A
(es)
|
2005-03-30 |
2007-11-21 |
Schering Corp |
Medicamentos y metodos que combinan un anticolinergico, un corticosteroide y un agonista beta de accion prolongada.
|
JP2008538758A
(ja)
|
2005-04-23 |
2008-11-06 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
抗コリン作用薬に加えてベータ受容体刺激薬及びステロイドを含有する吸入用の医薬組成物
|
GB0523653D0
(en)
|
2005-11-21 |
2005-12-28 |
Novartis Ag |
Organic compounds
|
CA2609429A1
(en)
|
2005-05-31 |
2006-12-07 |
Boehringer Ingelheim International Gmbh |
Medicament containing a betamimetic in conjunction with an anticholinergic and a pde iv inhibitor
|
WO2007009164A1
(en)
|
2005-07-15 |
2007-01-25 |
Eiffel Technologies Limited |
Method of particle formation
|
CN100560598C
(zh)
|
2005-07-26 |
2009-11-18 |
上海奥锐特国际贸易有限公司 |
氟替卡松丙酸酯的合成方法
|
GB0523656D0
(en)
|
2005-11-21 |
2005-12-28 |
Novartis Ag |
Organic compounds
|
GB0523655D0
(en)
|
2005-11-21 |
2005-12-28 |
Novartis Ag |
Organic compounds
|
GB0523654D0
(en)
|
2005-11-21 |
2005-12-28 |
Novartis Ag |
Organic compounds
|
PT2098248E
(pt)
|
2005-12-21 |
2012-08-27 |
Meda Pharma Gmbh & Co Kg |
Combinação de anticolinérgicos, glucocorticóides e agonistas de beta 2 para o tratamento de doenças inflamatórias
|
US8263645B2
(en)
|
2006-02-03 |
2012-09-11 |
Pari Pharma Gmbh |
Disodium cromoglycate compositions and methods for administering same
|
EP1981475A2
(en)
|
2006-02-09 |
2008-10-22 |
Schering Corporation |
Pharmaceutical formulations
|
CA2653105A1
(en)
|
2006-05-24 |
2007-11-29 |
Boehringer Ingelheim International Gmbh |
Novel medicament combinations for the treatment of respiratory diseases
|
GB0613161D0
(en)
|
2006-06-30 |
2006-08-09 |
Novartis Ag |
Organic Compounds
|
GB0614621D0
(en)
|
2006-07-24 |
2006-08-30 |
3M Innovative Properties Co |
Metered dose dispensers
|
EP1894568A1
(en)
|
2006-08-31 |
2008-03-05 |
Novartis AG |
Pharmaceutical compositions for the treatment of inflammatory or obstructive airway diseases
|
EP2327403A3
(en)
|
2007-02-19 |
2011-08-31 |
Cipla Limited |
Pharmaceutical combinations of at least two bronchodilators
|
EP2036572A1
(en)
|
2007-09-04 |
2009-03-18 |
Novo Nordisk A/S |
Process for drying a protein, a protein particle and a pharmaceutical composition comprising the protein particle
|
GB0801876D0
(en)
|
2008-02-01 |
2008-03-12 |
Vectura Group Plc |
Suspension formulations
|
FR2940162B1
(fr)
|
2008-12-22 |
2011-02-25 |
Boehm & Cie Ets |
Outil de frappe multi-usages a mecanisme absorbant l'energie transmise au moyen de prehension
|
WO2010097188A1
(en)
|
2009-02-25 |
2010-09-02 |
Chiesi Farmaceutici S.P.A. |
Inhalation particles comprising a salt of carmoterol and a corticosteroid
|
US8815258B2
(en)
|
2009-05-29 |
2014-08-26 |
Pearl Therapeutics, Inc. |
Compositions, methods and systems for respiratory delivery of two or more active agents
|
EP3106149B1
(en)
*
|
2009-05-29 |
2019-11-20 |
Pearl Therapeutics, Inc. |
Compositions for pulmonary delivery of long-acting muscarinic antagonists and long-acting beta-2 adrenergic receptor agonists and associated methods and systems
|
US20150093440A1
(en)
†
|
2010-10-15 |
2015-04-02 |
Glaxo Group Limited |
Aggregate nanoparticulate medicament formulations, manufacture and use thereof
|
EP2749277A3
(en)
|
2011-02-17 |
2014-08-27 |
Cipla Limited |
Combination of glycopyrronium and vilanterol
|
JO3510B1
(ar)
*
|
2011-03-04 |
2020-07-05 |
Heptares Therapeutics Ltd |
استخدام جلايكوبيرولات لعلاج عدم انتظام دقات القلب
|
EP2709447A4
(en)
|
2011-05-17 |
2014-10-22 |
Pearl Therapeutics Inc |
COMPOSITIONS, METHODS AND SYSTEMS FOR RESPIRATORY ADMINISTRATION OF AT LEAST TWO ACTIVE AGENTS
|
US20120325942A1
(en)
|
2011-06-27 |
2012-12-27 |
General Electric Company |
Jet milling of boron powder using inert gases to meet purity requirements
|
CN105188679B
(zh)
|
2013-03-15 |
2018-10-16 |
珍珠治疗公司 |
用于微粒晶体材料的状态调节的方法和系统
|